The psychedelic model of schizophrenia: the case of N,N-dimethyltryptamine.
about
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 yearsRecent advances in the neuropsychopharmacology of serotonergic hallucinogensRisk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloidsMethodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine.Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in ratsUrinary excretion of n,n-dimethylated tryptamines in chronic schizophrenia. A review of the present status of the hypothesis.In vivo kinetics and displacement study of a carbon-11-labeled hallucinogen, N,N-[11C]dimethyltryptamine.Bufotenine reconsidered.Drug-induced psychosis: how to avoid star gazing in schizophrenia research by looking at more obvious sources of light.Neuropharmacology of N,N-dimethyltryptamineClinical applications of hallucinogens: A review.Tolerance and cross-tolerance to head twitch behavior elicited by phenethylamine- and tryptamine-derived hallucinogens in mice.Pharmacologic challenge in ERP research.Behavioural changes induced by N,N-dimethyl-tryptamine in rodentsA critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955-2010.What can we learn about schizophrenia from studying the human model, drug-induced psychosis?Loose associations: straight and crooked thinking and the group of schizophrenias.NMDA receptor function, memory, and brain aging.Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies.Naloxone enhancement of DMT and LSD-25 induced suppression of food-rewarded bar pressing behavior in the rat.Neurotoxic action of kainic acid.Schizophrenia: some current neurochemical approaches.Mushrooms and madness. Hallucinogenic mushrooms and some psychopharmacological implications.On the physiology of metazoa.Ethnopharmacology and taxonomy of Mexican psychodysleptic plants.The excretion of dimethyltryptamine in psychiatric patients.The stages of schizophrenia and their management.Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample.Rat and mouse brain histamine N-methyltransferase: modulation by methylated indoleamines.Indolethylamine-N-methyltransferase Polymorphisms: Genetic and Biochemical Approaches for Study of Endogenous N,N,-dimethyltryptamine.N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function
P2860
Q26746137-2DE3E559-6A44-45D8-A24C-E5EBECE07255Q27027381-6D966A7B-4975-4EA6-B469-BF7CC8D10728Q28315282-05C55312-DEB8-4222-93FB-41D39E9F2AF2Q33740814-01A1E0C2-BFD5-4CA5-9BC9-175B1CA1938BQ33833054-9BB0A8DC-9F2F-4C6E-A697-608485D82D77Q33862039-62950082-8A43-4546-A6E3-615B1B8F9B47Q34180718-0641D488-5FE4-4AEB-8AC5-B0B5AB9D0DF1Q34201635-6EC8F848-C67C-4F08-AB3B-F9D9B8E1B426Q34509725-F9858E48-9319-4DC6-9173-08E8BEAC27FFQ34524116-EEEF9907-3E97-4D14-B71E-56BFA69C5C9FQ34535259-FCB17AE7-16D4-4788-9CA7-55B0CC9C85DAQ35024752-F062487F-386B-455F-8497-D5D707C0CCDCQ35670925-6C3541FC-FEA1-46FE-BEC8-BDF082C57253Q36096563-2550EA3C-CB2F-4C36-ABA5-FEF125689765Q37988834-432FF7F7-B8DC-4DE9-910D-B319593415C4Q38153344-C4A2F5EE-508E-404F-9660-DB7913805766Q38503626-63086DB2-5907-43A6-9235-56180BF9A6A4Q38578480-11C6EA14-2006-4B7B-BD6A-B0C819251CF9Q38816768-449DA1F2-B4CD-46F7-9C71-3329ABF632A9Q39673794-9E6DF4FB-C4FE-4B0D-87A0-2C77384A3532Q40135643-94798DC3-9F31-4079-8B6B-B3C1B5E90C8DQ40151501-1D701B88-5335-487C-80D2-0309FE3AF463Q40258983-6D077FCE-9F05-4F1F-9299-AF401165E59FQ40987081-A1CD936B-9E14-4424-BB32-30626572AE6FQ41147350-37D01879-EDC2-4825-AD35-551422B0A776Q42807375-7A8A5191-C001-472F-9D37-24DF6C9C615CQ43128063-18DB0F25-FB46-4122-8B85-4E0E8E043D50Q45383954-47181562-0BA0-4FDD-BBE3-529592B6C390Q48215061-1566733B-C364-488C-8FFE-A1E9CF062083Q54992302-A5A923C9-1735-400E-BDDF-F2E356D03FFBQ57075471-E8EF157A-A79E-43F5-9EE5-52548390D8BF
P2860
The psychedelic model of schizophrenia: the case of N,N-dimethyltryptamine.
description
1976 nî lūn-bûn
@nan
1976 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1976 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
name
The psychedelic model of schizophrenia: the case of N,N-dimethyltryptamine.
@ast
The psychedelic model of schizophrenia: the case of N,N-dimethyltryptamine.
@en
type
label
The psychedelic model of schizophrenia: the case of N,N-dimethyltryptamine.
@ast
The psychedelic model of schizophrenia: the case of N,N-dimethyltryptamine.
@en
prefLabel
The psychedelic model of schizophrenia: the case of N,N-dimethyltryptamine.
@ast
The psychedelic model of schizophrenia: the case of N,N-dimethyltryptamine.
@en
P2093
P356
P1476
The psychedelic model of schizophrenia: the case of N,N-dimethyltryptamine.
@en
P2093
P304
P356
10.1176/AJP.133.2.203
P407
P577
1976-02-01T00:00:00Z